{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:27:12Z","timestamp":1791354432712,"version":"4.3.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the key research and development project of Sichuan science and technology plan","award":["2021YFS0200"],"award-info":[{"award-number":["2021YFS0200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03425-y","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T07:01:45Z","timestamp":1729926105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical features and effects of cyclosporine in the treatment of psoriasis: a systemic review and meta-analysis"],"prefix":"10.1007","volume":"316","author":[{"given":"Zaibing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoqiang","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peimei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,26]]},"reference":[{"key":"3425_CR1","doi-asserted-by":"publisher","unstructured":"Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of Psoriasis. Lancet 9583370 Epub 2007\/07\/31. https:\/\/doi.org\/10.1016\/s0140-6736(07)61128-3","DOI":"10.1016\/s0140-6736(07)61128-3"},{"issue":"4","key":"3425_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman NJ (2020) Management of Psoriasis as a systemic disease: what is the evidence? Br J Dermatol 182(4):840\u2013848 Epub 2019\/06\/22. https:\/\/doi.org\/10.1111\/bjd.18245","journal-title":"Br J Dermatol"},{"issue":"1","key":"3425_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ad.2018.05.009","volume":"110","author":"S Gonz\u00e1lez-Parra","year":"2019","unstructured":"Gonz\u00e1lez-Parra S, Daud\u00e9n E (2019) Psoriasis and Depression: the role of inflammation. Actas Dermosifiliogr (Engl Ed) 110(1):12\u201319 Epub 2018\/12\/05. https:\/\/doi.org\/10.1016\/j.ad.2018.05.009","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"3425_CR4","doi-asserted-by":"publisher","unstructured":"Langley RG, Krueger GG, Griffiths CE, Psoriasis (2005) Epidemiology, Clinical Features, and Quality of Life. Ann Rheum Dis 64 Suppl 2(Suppl 2):ii18-23; discussion ii4-5. Epub 2005\/02\/15. https:\/\/doi.org\/10.1136\/ard.2004.033217","DOI":"10.1136\/ard.2004.033217"},{"issue":"5","key":"3425_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1208\/s12249-021-02057-z","volume":"22","author":"P Biswasroy","year":"2021","unstructured":"Biswasroy P, Pradhan D, Kar B, Ghosh G, Rath G (2021) Recent Advancement in Topical Nanocarriers for the treatment of Psoriasis. AAPS PharmSciTech 22(5):164 Epub 2021\/05\/28. https:\/\/doi.org\/10.1208\/s12249-021-02057-z","journal-title":"AAPS PharmSciTech"},{"key":"3425_CR6","unstructured":"Yuling S (2023) Interpretation of Guideline for the diagnosis and treatment of Psoriasis in China(2023 Edition). J TONGJI University(Medical Science) 44(05):631\u2013633"},{"issue":"1","key":"3425_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5070\/D32J7336W6","volume":"6","author":"S Feldman","year":"2000","unstructured":"Feldman S (2000) Advances in Psoriasis Treatment. Dermatol Online J 6(1):4 Epub 2001\/05\/01","journal-title":"Dermatol Online J"},{"key":"3425_CR8","unstructured":"Yuling S (2023) Interpretation of Guideline for the Diagnosis and Treatment of Psoriasis in China(2023 Edition). Journal of Tongji University(Medical Science) 44(05):631-3"},{"issue":"21 Suppl","key":"3425_CR9","first-page":"S403","volume":"23","author":"JJ Wu","year":"2017","unstructured":"Wu JJ (2017) Contemporary management of moderate to severe plaque psoriasis. Am J Manag Care 23(21 Suppl):S403\u2013s16 Epub 2018\/01\/04","journal-title":"Am J Manag Care"},{"issue":"4","key":"3425_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00403-018-1808-x","volume":"310","author":"AG Florek","year":"2018","unstructured":"Florek AG, Wang CJ, Armstrong AW (2018) Treatment preferences and treatment satisfaction among Psoriasis patients: a systematic review. Arch Dermatol Res 310(4):271\u2013319 Epub 2018\/02\/15. https:\/\/doi.org\/10.1007\/s00403-018-1808-x","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"3425_CR11","doi-asserted-by":"publisher","first-page":"15162","DOI":"10.1021\/acsami.3c00058","volume":"15","author":"H Wang","year":"2023","unstructured":"Wang H, Fu Y, Liu P, Qu F, Du S, Li Y et al (2023) Supramolecular Dissolving Microneedle Patch Loading Hydrophobic glucocorticoid for effective psoriasis treatment. ACS Appl Mater Interfaces 15(12):15162\u201315171 Epub 2023\/03\/15. https:\/\/doi.org\/10.1021\/acsami.3c00058","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"3425_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","volume":"15","author":"M Oray","year":"2016","unstructured":"Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS (2016) Long-Term Side effects of glucocorticoids. Expert Opin Drug Saf 15(4):457\u2013465 Epub 2016\/01\/21. https:\/\/doi.org\/10.1517\/14740338.2016.1140743","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"3425_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","volume":"20","author":"AK McDonough","year":"2008","unstructured":"McDonough AK, Curtis JR, Saag KG (2008) The epidemiology of glucocorticoid-Associated adverse events. Curr Opin Rheumatol 20(2):131\u2013137 Epub 2008\/03\/20. https:\/\/doi.org\/10.1097\/BOR.0b013e3282f51031","journal-title":"Curr Opin Rheumatol"},{"key":"3425_CR14","doi-asserted-by":"publisher","first-page":"102460","DOI":"10.1016\/j.jaut.2020.102460","volume":"110","author":"C Chang","year":"2020","unstructured":"Chang C, Greenspan A, Gershwin ME (2020) The Pathogenesis, diagnosis and clinical manifestations of Steroid-Induced Osteonecrosis. J Autoimmun 110:102460 Epub 2020\/04\/21. https:\/\/doi.org\/10.1016\/j.jaut.2020.102460","journal-title":"J Autoimmun"},{"issue":"1","key":"3425_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/09546634.2020.1757017","volume":"33","author":"F Marsili","year":"2022","unstructured":"Marsili F, Travaglini M, Stinco G, Manzoni R, Tiberio R, Prignano F et al (2022) Effectiveness of Cyclosporine a in patients with moderate to severe plaque psoriasis in a real-life clinical setting in Italy: the transition study. J Dermatolog Treat 33(1):401\u2013407 Epub 2020\/05\/01. https:\/\/doi.org\/10.1080\/09546634.2020.1757017","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"3425_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.23736\/s0392-0488.16.05301-3","volume":"152","author":"D Colombo","year":"2017","unstructured":"Colombo D, Chimenti S, Grossi PA, Marchesoni A, Foti R, Calzavara-Pinton P et al (2017) Efficacy of Cyclosporine a as Monotherapy in patients with psoriatic arthritis: a subgroup analysis of the Synergy Study. G Ital Dermatol Venereol 152(3):297\u2013301 Epub 2016\/02\/04. https:\/\/doi.org\/10.23736\/s0392-0488.16.05301-3","journal-title":"G Ital Dermatol Venereol"},{"issue":"5","key":"3425_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/09546634.2015.1120852","volume":"27","author":"V Di Lernia","year":"2016","unstructured":"Di Lernia V, Stingeni L, Boccaletti V, Calzavara Pinton PG, Guarneri C, Belloni Fortina A et al (2016) Effectiveness and safety of Cyclosporine in Pediatric Plaque psoriasis: a multicentric retrospective analysis. J Dermatolog Treat 27(5):395\u2013398 Epub 2015\/11\/17. https:\/\/doi.org\/10.3109\/09546634.2015.1120852","journal-title":"J Dermatolog Treat"},{"issue":"12","key":"3425_CR18","doi-asserted-by":"publisher","first-page":"e15917","DOI":"10.1111\/dth.15917","volume":"35","author":"G Gallo","year":"2022","unstructured":"Gallo G, Mastorino L, Baril\u00e0 D, Cattel F, Panzone M, Quaglino P et al (2022) Topical Cyclosporine Hydrogel Preparation: a new therapeutic option in the treatment of nail psoriasis. Dermatol Ther 35(12):e15917 Epub 2022\/10\/11. https:\/\/doi.org\/10.1111\/dth.15917","journal-title":"Dermatol Ther"},{"issue":"3","key":"3425_CR19","doi-asserted-by":"publisher","first-page":"e12875","DOI":"10.1111\/dth.12875","volume":"32","author":"JR Hong","year":"2019","unstructured":"Hong JR, Lee YW, Choe YB, Ahn KJ (2019) Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice. Dermatol Ther 32(3):e12875 Epub 2019\/03\/19. https:\/\/doi.org\/10.1111\/dth.12875","journal-title":"Dermatol Ther"},{"issue":"2","key":"3425_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s40262-023-01341-4","volume":"63","author":"J Greenzaid","year":"2024","unstructured":"Greenzaid J, Feldman S (2024) Clinical pharmacokinetic and pharmacodynamic considerations in the treatment of moderate-to-severe psoriasis. Clin Pharmacokinet 63(2):137\u2013153 Epub 2024\/01\/28. https:\/\/doi.org\/10.1007\/s40262-023-01341-4","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"3425_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/bjd\/ljad004","volume":"188","author":"OA Alabas","year":"2023","unstructured":"Alabas OA, Mason KJ, Yiu ZZN, Hampton PJ, Reynolds NJ, Owen CM et al (2023) Effectiveness and persistence of Acitretin, Ciclosporin, Fumaric Acid Esters and Methotrexate for patients with moderate-to-severe psoriasis: a Cohort Study from Badbir. Br J Dermatol 188(5):618\u2013627 Epub 2023\/02\/11. https:\/\/doi.org\/10.1093\/bjd\/ljad004","journal-title":"Br J Dermatol"},{"issue":"1","key":"3425_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13643-022-01994-5","volume":"11","author":"EBM Elsman","year":"2022","unstructured":"Elsman EBM, Butcher NJ, Mokkink LB, Terwee CB, Tricco A, Gagnier JJ et al (2022) Study protocol for developing, piloting and disseminating the Prisma-Cosmin Guideline: a New Reporting Guideline for systematic reviews of Outcome Measurement instruments. Syst Rev 11(1):121 Epub 2022\/06\/14. https:\/\/doi.org\/10.1186\/s13643-022-01994-5","journal-title":"Syst Rev"},{"key":"3425_CR23","unstructured":"Higgins J (ed) (2011) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration"},{"issue":"9997","key":"3425_CR24","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/s0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP, Psoriasis (2015) Lancet 386(9997):983\u2013994 Epub 2015\/05\/31. https:\/\/doi.org\/10.1016\/s0140-6736(14)61909-7","journal-title":"Lancet"},{"issue":"12","key":"3425_CR25","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.annder.2011.10.004","volume":"138","author":"C Paul","year":"2011","unstructured":"Paul C, Garat H (2011) [Cyclosporine]. Ann Dermatol Venereol 138(12):836\u2013838 Epub 2011\/12\/06. https:\/\/doi.org\/10.1016\/j.annder.2011.10.004","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"3425_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41397-022-00291-7","volume":"23","author":"C Antonatos","year":"2023","unstructured":"Antonatos C, Patsatsi A, Zafiriou E, Stavrou EF, Liaropoulos A, Kyriakoy A et al (2023) Protein Network and Pathway Analysis in a Pharmacogenetic Study of Cyclosporine Treatment Response in Greek patients with psoriasis. Pharmacogenomics J 23(1):8\u201313 Epub 2022\/10\/14. https:\/\/doi.org\/10.1038\/s41397-022-00291-7","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"3425_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12882-019-1575-8","volume":"20","author":"HY Li","year":"2019","unstructured":"Li HY, Zhang X, Zhou T, Zhong Z, Zhong H (2019) Efficacy and safety of Cyclosporine a for patients with steroid-resistant nephrotic syndrome: a Meta-analysis. BMC Nephrol 20(1):384 Epub 2019\/10\/28. https:\/\/doi.org\/10.1186\/s12882-019-1575-8","journal-title":"BMC Nephrol"},{"issue":"7","key":"3425_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1097\/ico.0000000000000123","volume":"33","author":"XQ Zhou","year":"2014","unstructured":"Zhou XQ, Wei RL (2014) Topical cyclosporine a in the treatment of Dry Eye: a systematic review and Meta-analysis. Cornea 33(7):760\u2013767 Epub 2014\/05\/13. https:\/\/doi.org\/10.1097\/ico.0000000000000123","journal-title":"Cornea"},{"key":"3425_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fphar.2018.00238","volume":"9","author":"FA Rahman","year":"2018","unstructured":"Rahman FA, Abdullah SS, Manan W, Tan LT, Neoh CF, Ming LC et al (2018) Efficacy and safety of Cyclosporine in Acute myocardial infarction: a systematic review and Meta-analysis. Front Pharmacol 9:238 Epub 2018\/07\/05. https:\/\/doi.org\/10.3389\/fphar.2018.00238","journal-title":"Front Pharmacol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03425-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03425-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03425-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:07:00Z","timestamp":1732205220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03425-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3425"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03425-y","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,26]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"705"}}